Previously submitted to: JMIR Research Protocols (no longer under consideration since Nov 23, 2022)
Date Submitted: Sep 15, 2022
Open Peer Review Period: Sep 13, 2022 - Nov 8, 2022
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Non-steroidal Anti-Inflammatory Drugs as protective Factor in Alzheimer's Diseases: a Systematic Review and Meta-Analysis Protocol
ABSTRACT
Background:
NSAIDs inhibit COX-2, which is responsible for regulating neurons leading to neurodegeneration in AD. AD is a neurodegenerative disease affecting the geriatric population, as it affects more than two third cases of dementia in the sphere. Results obtained from experimental and observational studies were unclear regarding the protective role of NSAIDs in AD, therefore this justifies the need for Meta-analysis.
Objective:
1) Role of NSAIDs, as a protective factor for AD in Experimental study design 2) Role of NSAIDs, as a protective factor for AD in Cohort study design 3) Role of NSAIDs, as a protective factor for AD in Case-Control study design
Methods:
Database search was PubMed, WebScience, and Embase. Experimental studies and Observational studies investigating the effect of NSAIDs on AD. For experimental studies indicators used were MMSE score, ADAS-cog score, CDR-sob score, NPI score, and Hazard ratio. Similarly for Observational studies, Odds Ratio and Relative Risk are used.
Results:
The study is ongoing, therefore the result of study still need to be obtained.
Conclusions:
As the result is not obtained, we can not concluded this study. Clinical Trial: PROSPERO [CRD42022301179]
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.